Some other very promising urinary biomarkers for AKI, including kidney injury molecule-1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL), have shown no significant ability to distinguish active renal disease from remission in AAG [24]. The gene discussed is HAVCR1; the disease is acute kidney injury.